The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of February 2025. The chart below provides highlights of key monograph ...

Newly confirmed Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. says he has a “generic list” of people he wants removed from his department. “I ...

His profanity-packed speeches and death threats to drug gangs were a feature of his successful campaign for the presidency in 2016. Among his statements during the campaign were: "Forget the laws ...

“And when we prioritize money at all costs, what we get is generic material that appeals to the most amount of people and we’re told that’s the best. It’s a dance we all do togethe ...

Quite frankly no, I hadn’t, until you brought it up. “Ever” is the first song on Flipper’s 1982 debut, Album – Generic Flipper, and it’s a doozy. In three short minutes, vocalist Bruce ...

FRANKFURT, March 9 (Reuters) - Europe should reduce its dependence on a small number of countries for vital drug supplies such as antibiotics and anaesthetics to boost the bloc's preparedness for ...

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Here’s more about this ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

A groundbreaking new study suggests that sotagliflozin, a drug recently approved to treat type 2 diabetes and kidney disease in people with additional cardiovascular risk factors, can also ...

When a drug-sniffing dog named Eureka flagged one of his bags, inspectors reportedly found two plastic jars and a Ziploc bag with candy inside.

In 2020, Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Four years later, she and her husband, Ken, halted the treatment.

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...